PLANT ADVANCED TECHNOLOGIES PAT: Winner of the Trophées de la Santé
02 September 2021 - 5:35PM
Business Wire
Regulatory News:
Plant Advanced Technologies PAT (Paris:ALPAT)
(Euronext Growth™- Paris - FR0010785790 - ALPAT), a plant
biotech company based in Lorraine, France, is an award winner at
the Trophées de la Santé event in the Health and Environment
Category.
This first award ceremony co-organized by the EBRA media group,
France’s leading regional daily press group, and the Welcoop
Cooperative, a major player in the French healthcare system in the
form of a cooperative of pharmacists, honored companies
intervening in the health sector in the Grand Est region on
Thursday, August 26, 2021 at the Zenith in Nancy. Among the hundred
or so companies from the region nominated, seven were selected in
the different categories by the jury members, healthcare sector
stakeholders and journalists specialized in the health sector and
innovation.
For PAT, this award is a testimony to its achievements as an
innovator in health, and in particular, for its TEM1657 drug
candidate for the treatment of psoriasis currently in preclinical
development with its pharmaceutical subsidiary Temisis, as well as
its role as a dynamic contributor to the regional economy.
As a reminder:
- Through its discovery of an original mechanism of action, the
company’s drug candidate is today a "First in Class" molecule with
anti-inflammatory properties.
- At the end of 2020, a first investor contributed €640,000
(with a €1.6 million contribution from PAT) resulting in a
pre-money valuation for Temisis of €40 million.
- Phase I clinical trials are planned for 2022.
Jean-Paul Fèvre, CEO of Plant Advanced Technologies PAT
commented: "Our company and research teams are honor to receive
this prize in the Health and Environment category which recognizes
our work in the discovery of innovative plant-based molecules to
meet the global health challenges of our time.”
______________________________
About PAT
Plant Advanced Technologies (PAT) is a plant biotechnology
company specialized in the identification, optimization and
production of rare new active plant compounds for cosmetics,
pharmaceutical, nutraceutical and fine chemicals markets. PAT
possesses unique plant-based expertise with a portfolio of
worldwide patents.
Plant Advanced Technologies PAT is listed on Euronext Growth™-
Paris ISIN: FR0010785790 - Ticker: ALPAT Reuters ALPAT.PA -
Bloomberg : ALPAT : FP
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210902005620/en/
PAT - Marketing Communications Department - Anne
Musci +33 (0)7 69 82 06 44 -
communication@plantadvanced.com
PAT - Investor Relations – Louis-Nicolas Vallas
+33 (0)6 20 64 32 86 42 - investisseur@plantadvanced.com
FIN’EXTENSO - Financial Communications – Isabelle
Aprile +33 (0)6 17 38 61 78 - i.aprile@finextenso.fr
Plant Advanced Technolog... (EU:ALPAT)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Plant Advanced Technolog... (EU:ALPAT)
Historical Stock Chart
Von Apr 2023 bis Apr 2024